Latest News:
Beauty Bytes with Dr. Kay
Long Lasting Toxins, DAXI, & Success with Dan Browne, CEO of Revance
Dermatology Times
Neurotoxin news: The DAXI differentiator
Media Inquiries
Revance Therapeutics, Inc.Sara J. Fahy, +1 (949) 887-4476sfahy@revance.comGeneral Media
Y&R PRJenifer Slaw, +1 (347) 971-0906jenifer.slaw@yr.comTrade Media
Nadine Tosk, +1 (504) 453-8344nadinepr@gmail.com